Literature DB >> 23771986

Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts.

Takuya Ueno1, Partha Dutta, Edmund Keliher, Florian Leuschner, Maulik Majmudar, Brett Marinelli, Yoshiko Iwamoto, Jose-Luiz Figueiredo, Thomas Christen, Filip K Swirski, Peter Libby, Ralph Weissleder, Matthias Nahrendorf.   

Abstract

BACKGROUND: Macrophages predominate among the inflammatory cells in rejecting allografts. These innate immune cells, in addition to allospecific T cells, can damage cardiomyocytes directly. METHODS AND
RESULTS: We explored whether sensitive positron emission tomography-computed tomography (PET-CT) imaging of macrophages-avid nanoparticles detects rejection of heart allografts in mice. In addition, we used the imaging method to follow the immunomodulatory impact of angiotensin-converting enzyme inhibitor therapy on myeloid cells in allografts. Dextran nanoparticles were derivatized with the PET isotope copper-64 and imaged 7 days after transplantation. C57BL/6 recipients of BALB/c allografts displayed robust positron emission tomography signal (standard uptake value allograft, 2.8±0.3; isograft control, 1.7±0.2; P<0.05). Autoradiography and scintillation counting confirmed the in vivo findings. We then imaged the effects of angiotensin-converting enzyme inhibitor (5 mg/kg enalapril). Angiotensin-converting enzyme inhibitor significantly decreased nanoparticle signal (P<0.05). Histology and flow cytometry showed a reduced number of myeloid cells in the graft, blood, and lymph nodes and diminished antigen presentation (P<0.05 versus untreated allografts). Angiotensin-converting enzyme inhibitor also significantly prolonged allograft survival (12 versus 7 days; P<0.0001).
CONCLUSIONS: Nanoparticle macrophage PET-CT detects heart transplant rejection and predicts organ survival by reporting on myeloid cells.

Entities:  

Keywords:  heart transplantation; imaging; macrophage; positron emission tomography/computed tomography

Mesh:

Substances:

Year:  2013        PMID: 23771986      PMCID: PMC3734553          DOI: 10.1161/CIRCIMAGING.113.000481

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  26 in total

Review 1.  The role of macrophages in allograft rejection.

Authors:  Kate R Wyburn; Matthew D Jose; Huiling Wu; Robert C Atkins; Steven J Chadban
Journal:  Transplantation       Date:  2005-12-27       Impact factor: 4.939

2.  In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI.

Authors:  Yijen L Wu; Qing Ye; Lesley M Foley; T Kevin Hitchens; Kazuya Sato; John B Williams; Chien Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-27       Impact factor: 11.205

3.  Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation.

Authors:  S A Lubitz; D A Baran; M M Alwarshetty; M J Zucker; L H Arroyo; M Chan; M C Courtney; R Correa; D Spielvogel; S L Lansman; A L Gass
Journal:  Transplant Proc       Date:  2006-06       Impact factor: 1.066

4.  Monocyte infiltration and kidney allograft dysfunction during acute rejection.

Authors:  R Girlanda; D E Kleiner; Z Duan; E A S Ford; E C Wright; R B Mannon; A D Kirk
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

Review 5.  Heart transplantation: a thirty-year perspective.

Authors:  Douglas N Miniati; Robert C Robbins
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

6.  Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis.

Authors:  Matthias Nahrendorf; Hanwen Zhang; Sheena Hembrador; Peter Panizzi; David E Sosnovik; Elena Aikawa; Peter Libby; Filip K Swirski; Ralph Weissleder
Journal:  Circulation       Date:  2007-12-24       Impact factor: 29.690

7.  Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

Authors:  Minnie Sarwal; Mei-Sze Chua; Neeraja Kambham; Szu-Chuan Hsieh; Thomas Satterwhite; Marilyn Masek; Oscar Salvatierra
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

8.  Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.

Authors:  Georg Heinze; Christa Mitterbauer; Heinz Regele; Reinhard Kramar; Wolfgang C Winkelmayer; Gary C Curhan; Rainer Oberbauer
Journal:  J Am Soc Nephrol       Date:  2006-02-15       Impact factor: 10.121

9.  Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts.

Authors:  W W Hancock; N M Thomson; R C Atkins
Journal:  Transplantation       Date:  1983-05       Impact factor: 4.939

10.  Flail tricuspid leaflet after multiple biopsies following orthotopic heart transplantation: echocardiographic and hemodynamic correlation.

Authors:  P A Tucker; B S Jin; C M Gaos; B Radovancevic; O H Frazier; S Wilansky
Journal:  J Heart Lung Transplant       Date:  1994 May-Jun       Impact factor: 10.247

View more
  16 in total

Review 1.  Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features.

Authors:  John C Stendahl; Albert J Sinusas
Journal:  J Nucl Med       Date:  2015-08-13       Impact factor: 10.057

2.  Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin.

Authors:  Hye-Yeong Kim; Ran Li; Thomas S C Ng; Gabriel Courties; Christopher Blake Rodell; Mark Prytyskach; Rainer H Kohler; Mikael J Pittet; Matthias Nahrendorf; Ralph Weissleder; Miles A Miller
Journal:  ACS Nano       Date:  2018-12-11       Impact factor: 15.881

3.  Opening the door to noninvasive assessment of cardiac transplant rejection: It's all in the preparation.

Authors:  Pavithra S Jayadeva; Nathan Better
Journal:  J Nucl Cardiol       Date:  2018-06-14       Impact factor: 5.952

Review 4.  Application of animal and human PET in cardiac research.

Authors:  Quan Wang; Zhi-Gang He; Shun-Yuan Li; Mao-Hui Feng; Hong-Bing Xiang
Journal:  Am J Cardiovasc Dis       Date:  2018-06-15

Review 5.  Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy.

Authors:  Marzia Marciello; Juan Pellico; Irene Fernandez-Barahona; Fernando Herranz; Jesus Ruiz-Cabello; Marco Filice
Journal:  Interface Focus       Date:  2016-12-06       Impact factor: 3.906

Review 6.  Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 2: Radiolabeled Probes.

Authors:  John C Stendahl; Albert J Sinusas
Journal:  J Nucl Med       Date:  2015-08-20       Impact factor: 10.057

7.  Continuing evolution in preparation protocols for 18FDG PET assessment of inflammatory or malignant myocardial disease.

Authors:  John P Bois; Panithaya Chareonthaitawee
Journal:  J Nucl Cardiol       Date:  2016-03-25       Impact factor: 5.952

Review 8.  Molecular Imaging of Acute Cardiac Transplant Rejection: Animal Experiments and Prospects.

Authors:  Yihan Chen; Li Zhang; Jinfeng Liu; Pingyu Zhang; Xiaoyuan Chen; Mingxing Xie
Journal:  Transplantation       Date:  2017-09       Impact factor: 4.939

9.  Molecular imaging of macrophage enzyme activity in cardiac inflammation.

Authors:  Muhammad Ali; Benjamin Pulli; John W Chen
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014-04-01

Review 10.  Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

Authors:  Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi
Journal:  Chem Rev       Date:  2019-09-06       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.